America's Healthy Future Act of 2009
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (289)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2011 · fourth_quarter · Health Issues
S 301 - Physician Payments Sunshine Act of 2009 HR 1191/S 1336 - Safe Drug Disposal Act of 2009 HR 1260/S 515 & 610 - Patent Reform Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1359/S 1292 - Secure and Responsible Drug Disposal Act of 2009 HR 1427/S 726 - Promoting Innovation and Access to Life-Saving Medicine Act HR 1548 - Pathway for Biosimilars Act HR 1706/S 369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 HR 3200/S 1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 HR 3590 - Patient Protection and Affordable Care Act HR 3962 - Affordable Health Care for America Act HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 4956 - Stop Oxy Abuse Act of 2010 HR 756 - National Pain Care Policy Act of 2009 HR 5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 HR 5809/S 3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 HR 6165/S 4018 - Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · fourth_quarter · Medicare/Medicaid
S 301 - Physician Payments Sunshine Act of 2009 HR 1191/S 1336 - Safe Drug Disposal Act of 2009 HR 1260/S 515 & 610 - Patent Reform Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1359/S 1292 - Secure and Responsible Drug Disposal Act of 2009 HR 1427/S 726 - Promoting Innovation and Access to Life-Saving Medicine Act HR 1548 - Pathway for Biosimilars Act HR 1706/S 369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 HR 3200/S 1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 HR 3590 - Patient Protection and Affordable Care Act HR 3962 - Affordable Health Care for America Act HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 4956 - Stop Oxy Abuse Act of 2010 HR 756 - National Pain Care Policy Act of 2009 HR 5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 HR 5809/S 3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 HR 6165/S 4018 - Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $120,000 · Firm income: Not reported
2011 · fourth_quarter · Copyright/Patent/Trademark
S 301 - Physician Payments Sunshine Act of 2009 HR 1191/S 1336 - Safe Drug Disposal Act of 2009 HR 1260/S 515 & 610 - Patent Reform Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1359/S 1292 - Secure and Responsible Drug Disposal Act of 2009 HR 1427/S 726 - Promoting Innovation and Access to Life-Saving Medicine Act HR 1548 - Pathway for Biosimilars Act HR 1706/S 369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 HR 3200/S 1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 HR 3590 - Patient Protection and Affordable Care Act HR 3962 - Affordable Health Care for America Act HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 4956 - Stop Oxy Abuse Act of 2010 HR 756 - National Pain Care Policy Act of 2009 HR 5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 HR 5809/S 3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 HR 6165/S 4018 - Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $120,000 · Firm income: Not reported
2011 · fourth_quarter · Alcohol and Drug Abuse
S 301 - Physician Payments Sunshine Act of 2009 HR 1191/S 1336 - Safe Drug Disposal Act of 2009 HR 1260/S 515 & 610 - Patent Reform Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1359/S 1292 - Secure and Responsible Drug Disposal Act of 2009 HR 1427/S 726 - Promoting Innovation and Access to Life-Saving Medicine Act HR 1548 - Pathway for Biosimilars Act HR 1706/S 369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 HR 3200/S 1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 HR 3590 - Patient Protection and Affordable Care Act HR 3962 - Affordable Health Care for America Act HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 4956 - Stop Oxy Abuse Act of 2010 HR 756 - National Pain Care Policy Act of 2009 HR 5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 HR 5809/S 3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 HR 6165/S 4018 - Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $120,000 · Firm income: Not reported
2011 · fourth_quarter · Medicare/Medicaid
H.R. 3962 Affordable Health Care For America Act; S.1796 Americas Healthy Future Act Of 2009; H.R. 3200 America's Affordable Health Choices Act of 2009. For all of the above, provisions relating to Medicare Special Needs Plans, especially risk adjustment, quality measurement, and compliance/oversight. Legislative and administrative rules and regulations related to Medicare Advantage and Special Needs Plans.
Client expense: $290,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · third_quarter · Medicare/Medicaid
H.R. 3962 Affordable Health Care For America Act; S.1796 Americas Healthy Future Act Of 2009; H.R. 3200 America's Affordable Health Choices Act of 2009. For all of the above, provisions relating to Medicare Special Needs Plans, especially risk adjustment, quality measurement, and compliance/oversight. Legislative and administrative rules and regulations related to Medicare Advantage and Special Needs Plans.
Client expense: $260,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2011 · second_quarter · Health Issues
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · second_quarter · Alcohol and Drug Abuse
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · second_quarter · Medicare/Medicaid
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · second_quarter · Copyright/Patent/Trademark
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · second_quarter · Medicare/Medicaid
H.R. 3962 Affordable Health Care For America Act; S.1796 Americas Healthy Future Act Of 2009; H.R. 3200 America's Affordable Health Choices Act of 2009. Legislative and administrative rules and regulations related to Medicare Advantage and Special Needs Plans. For all of the above, provisions relating to Medicare Special Needs Plans, especially Risk Adjustment, Quality Measurement, and Compliance / Oversight.
Client expense: $260,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2011 · first_quarter · Medicare/Medicaid
H.R. 3962 Affordable Health Care For America Act; S.1796 Americas Healthy Future Act Of 2009; H.R. 3200 America's Affordable Health Choices Act of 2009. Legislative and administrative rules and regulations related to Medicare Advantage and Special Needs Plans. For all of the above, provisions relating to Medicare Special Needs Plans, especially Risk Adjustment, Quality Measurement, and Compliance / Oversight.
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2011 · first_quarter · Medicare/Medicaid
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · first_quarter · Health Issues
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · first_quarter · Alcohol and Drug Abuse
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · first_quarter · Copyright/Patent/Trademark
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · first_quarter · Medicare/Medicaid
Healthcare reform; healthcare regulations; Medicare Part D; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare demonstration projects for durable medical equipment; importation of prescription drugs; home infusion; disclosure of PBM information; changes to drug benefits offered under the FEHBP and increasing healthcare value; competitive bidding H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections H.R. 3962 - Affordable Care for All America Act; all sections S. 1796 - America's Healthy Future Act; sections 1001 - 2221 H.R. 3790 - To amend Title XVIII of the Social Security Act to repeal the Medicare Competitive Acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); all sections Public Law 111-152 - Health Care and Education Reconciliation Act (formerly H.R. 4872); all sections H.R. 1041 - Fairness in Medicare Bidding Act (FIMBA); section 2
Client expense: $1,080,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Personnel Management (OPM), Postal Rate Commission, Postal Regulatory Commission, SENATE, U.S. Postal Service (USPS)
2011 · first_quarter · Medicare/Medicaid
H.R. 3962 Affordable Health Care For America Act; S.1796 Americas Healthy Future Act Of 2009; H.R. 3200 America's Affordable Health Choices Act of 2009. Legislative and administrative rules and regulations related to Medicare Advantage and Special Needs Plans. For all of the above, provisions relating to Medicare Special Needs Plans, especially Risk Adjustment, Quality Measurement, and Compliance / Oversight.
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2011 · first_quarter · Pharmacy
Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796).
Client expense: Not reported · Firm income: $20,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Medicare/Medicaid
Medicare physician payment; Health Care Quality; Medical Imaging; Medicare reimbursement (practice expense); comparative effectiveness; radiation safety; Resource Use reports; Unapproved drugs initiative (nitroglycerin); Health Information Technology; HR 4371, a bill to revise practice expenses; S. 1796, America's Healthy Future Act of 2009; HR 3200, America's Affordable Health Choices Act; HR 3962, Affordable Health Care for America Act; HR 3590, Patient Protection and Affordable Care Act; HR 4872, the Health Care and Education Affordability and Reconcilation Act.
Client expense: $520,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE
2010 · fourth_quarter · Health Issues
S. 1796, to provide affordable, quality health care for all Americans and reduce the growth in health care spending HR 1558 To amend title I of the Employee Retirement Income Security Act of 1974, title XXVII of the Public Health Service Act, and the Internal Revenue Code of 1986 to prohibit preexisting condition exclusions in group health plans and health insurance coverage in the group and individual markets H.R. 2520 to provide comprehensive solutions for the health care system of the United States, and for other purposes HR 3200 America's Affordable Health Choices Act of 2009 H.R.3590: An act entitled The Patient Protection and Affordable Care Act. H.R.3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending. HR 4757 to provide for the establishment of a health insurance rate authority to establish limits on premium rating HR 4872 The bill makes a number of health-related financing and revenue changes to the Patient Protection and Affordable Care Act enacted by H.R.3590 and modifies higher education assistance provisions S 623 To amend title I of the Employee Retirement Income Security Act of 1974, title XXVII of the Public Service Act, and the Internal Revenue Code of 1986 to prohibit preexisting condition exclusions in group health plans and in health insurance coverage in the group and individual markets S 803 A bill to amend the Internal Revenue Code of 1986 to provide a tax credit to employers for the costs of implementing wellness programs, and for other purposes. S. 1099 to provide comprehensive solutions for the health care system of the United States, and for other purposes S. 1679 the Affordable Health Choices Act -- An original bill to make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce. S. 1796, to provide affordable, quality health care for all Americans and reduce the growth in health care spending S. 3078 to provide for the establishment of a health insurance rate authority to establish limits on premium rating
Client expense: $425,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA
Client expense: $1,000,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · fourth_quarter · Health Issues
General issues related to healthcare, healthcare reimbursement, and healthcare reform; S.1213 - Patient Centered Outcomes Research Act (all provisions); S.1142 - Informed Health Care Decision Making Act (all provisions); Issues related to FDA 510(K) legislative changes; S.1679 - Affordable Health Choice Act - issues related to comparative effectiveness and physicians sunshine; H.R. 3590 - Patient Protection and Affordable Care Act of 2009 - issues related to comparative effectiveness and physicians sunshine and medical device tax; S. 1796 - "The Americas Healthy Future Act of 2009" - issues related to comparative effectiveness, physicians sunshine and medical device fee; H.R. 4872 - The Healthcare & Education Affordability Reconciliation Act of 2010 - issues related to comparative effectiveness, physicians sunshine and medical device fee; Issues relating to the medical device tax/fee in general; H. Res. 1438 - Promoting Increased Awarness and Diagnosis of Peripheral Arterial Disease (all provisions); General issues related to BPA.
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
General issues related to healthcare, healthcare reimbursement, and healthcare reform, and the FDA device approval process; S.1213 - Patient Centered Outcomes Research Act (all provisions); S.1142 - Informed Health Care Decision Making Act (all provisions); Issues related to FDA 510(K) legislative changes; S.1679 - Affordable Health Choice Act - issues related to comparative effectiveness and physicians sunshine; H.R. 3590 - Patient Protection and Affordable Care Act of 2009 - issues related to comparative effectiveness and physicians sunshine and medical device tax; S. 1796 - "The Americas Healthy Future Act of 2009" - issues related to comparative effectiveness, physicians sunshine and medical device fee; H.R. 4872 - The Healthcare & Education Affordability Reconciliation Act of 2010 - issues related to comparative effectiveness, physicians sunshine and medical device fee; Issues relating to the medical device tax/fee in general, H. Res. 1438 - Promoting increased Awareness and Diagnosis of Peripheral Arterial Disease (all provisions).
Client expense: $450,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
General issues related to healthcare, healthcare reimbursement, and healthcare reform; S.1213 - Patient Centered Outcomes Research Act (all provisions); S.1142 - Informed Health Care Decision Making Act (all provisions); Issues related to FDA 510(K) legislative changes. S.1679 - Affordable Health Choice Act - provisions related to comparative effectiveness and physicians sunshine; H.R. 3590 - Patient Protection and Affordable Care Act of 2009 - provisions related to comparative effectiveness and physicians sunshine and medical device tax; S. 1796 - "The Americas Healthy Future Act of 2009" - provisions related to comparative effectiveness, physicians sunshine and medical device fee; H.R. 4872 - The Healthcare & Education Affordability Reconciliation Act of 2010 - provisions related to comparative effectiveness, physicians sunshine and medical device fee; Issues relating to the medical device tax/fee in general.
Client expense: $480,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Health Issues
General issues related to healthcare, healthcare reimbursement, and healthcare reform; S. 1213 - Patient Centered Outcomes Research Act (all provisions); H.R. 2502 - Comparative Effective Research Act of 2009 (all provisions); S. 1142 - Informed Health Care Decision Making Act (all provisions). S. 1679 - Affordable Health Choice Act (all provisions); H.R. 3590 - Patient Protection and Affordable Care Act of 2009 (all provisions); H.R. 3962 - Affordable Healthcare for American Act (all provisions); S. 1796 - "The Americas Healthy Future Act of 2009" (all provisions); Issues relating to the medical device tax/fee; Senate Finance Committee Healthcare Reform Bill; H.R. 4872 - The Healthcare & Education Affordability Reconciliation Act of 2010 (all provisions).
Client expense: $490,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
S 1796, S 1679, HR 3962, HR 3590 (Health Care Reform). HR 1204 (Antitrust exemption for pharmacists) HR 1493 (Antitrust exemption for physicians) HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT). HR 1427/S 726/ HR 1548 (FDA PAthway to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (Generic/brand settlements). S. 93 (establish FEHBP for small employers) S. 391/H.R. 1321 (National health) H.R. 676/S. 703 (single payer); PL 111-148; PL 111-152.
Client expense: $1,641,400 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2010 · third_quarter · Health Issues
Monitor and track, advising client on health care reform issues, as they relate to pharmacy benefit managers (PBMs). In particular, advise on effects of Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Monitor and advise regarding H.R.4872 (Reconciliation Bill).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2010 · third_quarter · Medicare/Medicaid
Monitor and track H.R. 904-the Drug Rebate Equalization Act of 2009. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Monitor and advise regarding H.R.4872 (Reconciliation Bill).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2010 · second_quarter · Health Issues
Monitor and track, advising client on health care reform issues, as they relate to pharmacy benefit managers (PBMs). In particular, advise on effects of Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Monitor and Advise regarding HR 4872 (Reconciliation Bill).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2010 · second_quarter · Medicare/Medicaid
Monitor and track H.R. 904-the Drug Rebate Equalization Act of 2009. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Monitor and Advise regarding HR 4872 (Reconciliation Bill).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2010 · first_quarter · Health Issues
Monitor and track, advising client on health care reform issues, as they relate to pharmacy benefit managers (PBMs). In particular, advise on effects of Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2010 · first_quarter · Medicare/Medicaid
Monitor and track, H.R. 904-the Drug Rebate Equalization Act of 2009. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796).
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES
2010 · first_quarter · Health Issues
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Client expense: $3,220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2010 · first_quarter · Medicare/Medicaid
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
Client expense: $3,220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2010 · fourth_quarter · Medicare/Medicaid
H.R. 3962 Affordable Health Care For America Act; S.1796 Americas Healthy Future Act Of 2009; H.R. 3200 America's Affordable Health Choices Act of 2009. Legislative and administrative rules and regulations related to Medicare Advantage and Special Needs Plans. For all of the above, provisions relating to Medicare Special Needs Plans, especially Risk Adjustment, Quality Measurement, and Compliance / Oversight.
Client expense: $280,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2010 · third_quarter · Medicare/Medicaid
H.R. 3962 Affordable Health Care For America Act; S.1796 Americas Healthy Future Act Of 2009; H.R. 3200 America's Affordable Health Choices Act of 2009. For all of the above, provisions relating to Medicare Special Needs Plans, especially Risk Adjustment, Quality Measurement, and Compliance / Oversight.
Client expense: $280,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2010 · first_quarter · Health Issues
Health care reform: America's Affordable Health Choices Act, H.R. 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S. 1679: Senate HELP and S. 1796: Senate Finance committee drafts); pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Client expense: $984,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Taxation/Internal Revenue Code
Therapeutic discovery tax credits (H.R. 3962, S. 1796); H.R. 3590; counter measure and orphan drug exemption from pharmaceutical excise tax; Implementation of Section 48D if the IRC, Implementation of Therapeutic Discovery Research Tax Credit.;H.R.5297, Small Business Jobs and Credit Act 2010; H.R.4213/S.3793 Tax Extenders Act of 2009; Small business capital gains incentives for biotech companies;AMT credits in lieu of bonus depreciation for biotech companies. H.R.4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010.
Client expense: Not reported · Firm income: $75,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2010 · fourth_quarter · Taxation/Internal Revenue Code
Therapeutic discovery tax credits (H.R. 3962, S. 1796); H.R. 3590; counter measure and orphan drug exemption from pharmaceutical excise tax; Implementation of Section 48D if the IRC, Implementation of Therapeutic Discovery Research Tax Credit.;H.R.5297, Small Business Jobs and Credit Act 2010; H.R.4213/S.3793 Tax Extenders Act of 2009; Small business capital gains incentives for biotech companies;AMT credits in lieu of bonus depreciation for biotech companies. H.R.4853, Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010.
Client expense: Not reported · Firm income: $75,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2010 · first_quarter · Telecommunications
H.R. 1: (PL 111-5, 123 Stat. 115 (2009)) The American Recovery and Reinvestment Act of 2009: Division A, Title I, Department of Agriculture, Rural Utilities Service; Division A, Title II, Department of Commerce, National Telecommunications and Information Administration; and Division B, Title VI, Broadband Technology Opportunities Program. All provisions related to the BIP and BTOP programs for the deployment of broadband to unserved and underserved areas throughout the United States. H.R. 2165 Bulk Power System Protection Act of 2009, all provisions related to the cybersecurity of bulk power systems. H.R. 2902 Broadband Internet Fairness Act, provisions related to the authorization of the FTC and the FCC both reviewing service plans of broadband Internet Service Providers to ensure plans are fair based on costs. H.R. 3458 Internet Preservation Act, all provisions concerning the preservation of Internet freedom. H.R. 6320 Communications and Video Accessibility Act, provisions related to enabling those with disabilities to have better access to emerging Internet Protocol-based communication and programming technologies. S. 418 Secondary Metal Theft Protection Act of 2009, commented on provisions related to record keeping by metal recycling agents; payment processes; possible enforcement tolls; and creation of "Do Not Buy" list. S. 773 Cybersecurity Act of 2009, all provisions related to ensuring the security of cyber communications. S.1266 Broadband Conduit Deployment Act, terms related to the requirement that broadband conduit be installed as part of certain highway construction projects. S. 1490 Personal Data Privacy and Security Act, all provisions related to the privacy and security of personal data. S. 1796 America's Healthy Future Act of 2009, provisions related to the excise tax and Medicare Part D. S. 2880 Rural Broadband Initiative Act of 2009, provisions related to the establishment and responsibilities of the Office of Rural Broadband Initiatives. S.2881 FCC Commissioners Technical Resource Enhancement Act, provision related to the appointment of technical staff at the Federal Communications Commission. Issues related to Cybersecurity, commented and proposed draft legislation concerning Cybersecurity as it affects communication service providers and information service providers. Issues related to Special Access, all proposals related to high capacity dedicated lines for voice and data traffic and the FCC's need for more complete data in order to adequately assess the issue. Issues related to Net Neutrality, all proposals concerning the sufficiency of the FCC's principles contained in its broadband policy statement. Issues related to Universal Service Reform, all proposals concerning the need for reform to ensure fair distribution of universal service support in high cost areas. Issues related to Traffic Pumping, all proposals addressing the affects of traffic pumping on common carriers. Issues related to Data Privacy, all proposals affecting the operations of common carriers. Issues related to Networx administration and implementation.
Client expense: $1,035,175 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA
Client expense: $1,000,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · fourth_quarter · Health Issues
H.R. 3590: An act entitled The Patient Protection and Affordable Care Act.-all provisions related to health, coverage, benefits and Medicaid (all provisions). H.R. 4872: An act to provide reconciliation pursuant to Title II of the concurrent resolution on the budget for fiscal year 2010. (S. Con. Res. 13). (all provisions) H.R. 1: American Recovery and Reinvestment Act of 2009 (all provisions) H.R. 1585: FIT Kids Act (all provisions) H.R.1586: FAA Air Transportation Modernization and Safety Improvement Act (all provisions related to FMAP) H.R. 3081: Continuing Appropriations Act, 2011 H.R. 4851: Continuing Extension Act of 2010 - Fiscally Responsible Relief for Our States Act of 2010 (all provisions related to health coverage, benefits and Medicaid) HR 4994: Taxpayer Assistance Act of 2010 (all provisions related to health coverage, benefits and Medicaid) H.R.5471: To amend the American Recovery and Reinvestment Act of 2009 to extend for 6 months the increase provided under that Act in the Medicaid Federal medical assistance percentage (FMAP). H.R.5712: Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (all provision regarding Childern's Health) H.R.6258: Fit for LIFE Act of 2010 (all provisions related to health coverage, benefits and Medicaid) S. 11: To restore the application of the 340B drug discount program to orphan drugs with respect to children's hospitals. (all provisions) S. 1796: Provide affordable, quality health care for all Americans and reduce the growth in health care spending (all provisions related to health coverage, benefits and Medicaid). S. 2898: Child Safety Care and Educational Continuity Act of 2010 (all provisions regarding Medicaid and CHIP) S. 3551: Fiscally Responsible Relief for Our States Act of 2010 (all provisions related to health coverage, benefits and Medicaid) S. 3793: Job Creation and Tax Cuts Act of 2010 (all provisions related to health coverage, benefits and Medicaid) HIT Certification Standards for Meaningful Use - 45 CFR Part 170 Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology; Final Rule (All provisions) State Exchanges - 45 CFR Part 170 Planning and Establishment of State-Level Exchanges; Request for Comments Regarding Exchange- Related Provisions in Title I of the Patient Protection and Affordable Care Act (Provisions affecting children) Medical homes for individuals with chronic conditions - Section 2703 of the Patient Protection and Affordable Care Act (PPACA) Non-payment for Hospital-Acquired Conditions - Section 2702 of the Patient Protection and Affordable Care Act Childrens Hospitals Graduate Medical Education -- Changes to Hospital Outpatient Prospective Payment System and CY 2011 Payment Rates; Changes to the Ambulatory System and CY 2011 Payment Rates; Proposed Changes to Payments to Hospitals for Certain Inpatient Hospital Services and for Graduate Medical Education Costs; and Proposed Changes to Physician Self-Referral Rules and Related Changes to Provider Agreement Regulations (Provisions affecting CHGME)
Client expense: $370,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, White House Office
2010 · fourth_quarter · Alcohol and Drug Abuse
S.301 - Physician Payments Sunshine Act of 2009 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Copyright/Patent/Trademark
S.301 - Physician Payments Sunshine Act of 2009 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Health Issues
S.301 - Physician Payments Sunshine Act of 2009 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Medicare/Medicaid
S.301 - Physician Payments Sunshine Act of 2009 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Health Issues
Combating Autism Act and reauthorization, ABLE Accounts Tax Legislation (HR 1205 and S493), ATAA, Health Care Reform (HR. 3200, essential benefits; S. 1796 America Healthy Future Act, essential benefits), Mental Health Parity
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), SENATE
2010 · fourth_quarter · Consumer Issues/Safety/Products
H.R.2221 - Data Accountability and Trust Act S.773 - Cybersecurity Act of 2009 S.778 - A bill to establish, within the Executive Office of the President, the Office of National Cybersecurity Advisor S.1796 - America's Healthy Future Act of 2009 H.R.4061- Cybersecurity Enhancement Act of 2010 H.R.3200 - America's Affordable Health Choices Act of 2009 S.1490 - Personal Data Privacy and Security Act S.139 - Data Breach Notification Act of 2009 S.3804 - Combating Online Infringement and Counterfeit Act S.3742 - Data Security and Breach Notification Act of 2010
Client expense: $1,680,000 · Firm income: Not reported
Government targets: Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Health Issues
HR 3590: PATIENT PROTECTION AND AFFORDABLE CARE ACT; ALL PROVISIONS AND GENERAL DISCUSSIONS RELATED TO THE LEGISLATION HR 3962: AFFORDABLE HEALTH CARE FOR AMERICA ACT; PROVISIONS RELATED TO PROPERTY-CASUALTY AND LIFE INSURANCE, GENERAL TRACKING OF LEGISLATION S 1796: AMERICA'S HEALTHY FUTURE ACT OF 2009; PROVISIONS RELATED TO PROPERTY-CASUALTY AND LIFE INSURANCE, GENERAL TRACKING OF LEGISLATION
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE